March 22, 2018 4:48 PM ET


Company Overview of EffRx Pharmaceuticals SA

Company Overview

EffRx, Inc. develops drug delivery solutions. It develops novel prescription and over the counter pharmaceuticals. The company offers Alendronate, a product for the treatment of osteoporosis. Its product development areas include osteoporosis, xerostomia, pain management, central nervous system, and metabolic disease/diabetes agents. The company was formerly known as Lifizz, Inc. and changed its name in 2002. EffRx, Inc. was founded in 1998 and is headquartered in Jupiter, Florida. The company has manufacturing locations in Switzerland. It has operations in Europe, Japan, and the United States.

Route de la Corniche 4

Epalinges S

Lausanne,  1066


Founded in 1998


41 21 651 90 74


41 21 652 26 38

Key Executives for EffRx Pharmaceuticals SA

Chief Executive Officer
Chief Financial Officer
Communications & Marketing Manager
Medical Affairs Director
International Marketing Director
Compensation as of Fiscal Year 2017.

EffRx Pharmaceuticals SA Key Developments

EffRx Pharmaceuticals SA Presents at BIO One-on-One Partnering™, Jan-07-2018

EffRx Pharmaceuticals SA Presents at BIO One-on-One Partnering™, Jan-07-2018 . Venue: San Francisco, California, United States.

EffRx Pharmaceuticals SA Announces Appointment of Paolo Agnoluzzi as Chief Financial Officer

EffRx Pharmaceuticals SA announced the appointment of Mr. Paolo Agnoluzzi as Chief Financial Officer, effective June 1, 2017. Mr. Agnoluzzi joined EffRx in August 2016 as Interim Chief Financial Officer and led the re-organization of the Finance Department. Among other achievements he executed a number of debt and equity transactions, including a capital increase. Mr. Agnoluzzi brings over 30 years of international financial experience, predominantly in biopharmaceutical companies. Most recently, he served as Finance Director for VistaJet Group. His responsibilities included acting as deputy CFO, leading the financial planning and analysis group, heading the treasury function and directing special projects within Finance.

EffRx Pharmaceuticals SA Appoints Lorenzo Bosisio as Chief Executive Officer

EffRx Pharmaceuticals SA announced that the company has made some changes and additions to its management team. Lorenzo Bosisio has been appointed as Chief Executive Officer effective July 1, 2016. Prior to his promotion to CEO, Bosisio served as Chief Commercial Officer since 2013. During his tenure in the company, he has built the commercial infrastructure from the ground, successfully launched the company's lead product, Binosto, enabling the transformation of the company from a drug development company to an integrated biopharmaceutical company with an international footprint.

Similar Private Companies By Industry

Company Name Region
Acino International AG Europe
Activen SA Europe
AL-S Pharma AG Europe
Albea Pharmaceuticals AG Europe
Alpen Pharma AG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EffRx Pharmaceuticals SA, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at